BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22505419)

  • 1. Towards the crystal structure elucidation of eukaryotic UDP-galactopyranose mutase.
    van Straaten KE; Routier FH; Sanders DA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):455-9. PubMed ID: 22505419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus.
    Dhatwalia R; Singh H; Oppenheimer M; Karr DB; Nix JC; Sobrado P; Tanner JJ
    J Biol Chem; 2012 Mar; 287(12):9041-51. PubMed ID: 22294687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.
    van Straaten KE; Routier FH; Sanders DA
    J Biol Chem; 2012 Mar; 287(14):10780-90. PubMed ID: 22334662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction.
    Mehra-Chaudhary R; Dai Y; Sobrado P; Tanner JJ
    Biochemistry; 2016 Feb; 55(6):833-6. PubMed ID: 26836146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus.
    Oppenheimer M; Poulin MB; Lowary TL; Helm RF; Sobrado P
    Arch Biochem Biophys; 2010 Oct; 502(1):31-8. PubMed ID: 20615386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutase.
    Dhatwalia R; Singh H; Solano LM; Oppenheimer M; Robinson RM; Ellerbrock JF; Sobrado P; Tanner JJ
    J Am Chem Soc; 2012 Oct; 134(43):18132-8. PubMed ID: 23036087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.
    Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of functional Leishmania major virulence factor UDP-galactopyranose mutase.
    Oppenheimer M; Valenciano AL; Sobrado P
    Biochem Biophys Res Commun; 2011 Apr; 407(3):552-6. PubMed ID: 21419104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification and preliminary X-ray crystallographic analysis of UDP-galactopyranose mutase from Deinococcus radiodurans.
    Karunan Partha S; Bonderoff SA; van Straaten KE; Sanders DA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Aug; 65(Pt 8):843-5. PubMed ID: 19652355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay.
    Martín Del Campo JS; Eckshtain-Levi M; Sobrado P
    Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, crystallization and preliminary X-ray diffraction data of UDP-galactopyranose mutase from Aspergillus fumigatus.
    Penman GA; Lockhart DE; Ferenbach A; van Aalten DM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):705-8. PubMed ID: 22684076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.
    Pierdominici-Sottile G; Cossio-Pérez R; Da Fonseca I; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2018 Jul; 57(26):3713-3721. PubMed ID: 29757624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.
    Dhatwalia R; Singh H; Oppenheimer M; Sobrado P; Tanner JJ
    Biochemistry; 2012 Jun; 51(24):4968-79. PubMed ID: 22646091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Control of UDP-Galactopyranose Mutase Inhibition.
    Wangkanont K; Winton VJ; Forest KT; Kiessling LL
    Biochemistry; 2017 Aug; 56(30):3983-3992. PubMed ID: 28608671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray crystallography reveals a reduced substrate complex of UDP-galactopyranose mutase poised for covalent catalysis by flavin.
    Gruber TD; Westler WM; Kiessling LL; Forest KT
    Biochemistry; 2009 Oct; 48(39):9171-3. PubMed ID: 19719175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
    Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
    J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, mechanism, and dynamics of UDP-galactopyranose mutase.
    Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P
    Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design.
    Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA
    Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.